2017-02-16,Windtree Therapeutics' Aerosolized KL4 Surfactant Reduces Lung Inflammation And Improves Survival In A High-Pathogen Avian Influenza Preclinical Study
2017-02-15,Windtree Therapeutics Completes $10.5 Million Private Offering
2017-02-15,Windtree Therapeutics To Host A Conference Call And Webcast At 8:00 AM On Thursday, February 16, 2017 To Provide Clinical And Financial Updates
2016-12-01,Windtree Therapeutics Announces Upcoming Presentations At Hot Topics In Neonatology
2016-11-28,Windtree Therapeutics' AEROSURF® (lucinactant For Inhalation) Phase 2a Data Presented At The 2016 International Congress Of Union Of European Neonatal And Perinatal Societies
2016-11-08,Windtree Therapeutics To Present At Stifel 2016 Healthcare Conference
2016-11-03,Windtree Therapeutics Preclinical Study Results Show Potential For KL4 Surfactant As Possible Medical Countermeasure To Radiation Exposure
2016-10-24,Windtree Releases Data From Lung Deposition Study In Non-Human Primates Demonstrating Uniform Distribution Of Aerosolized KL4 Surfactant In All Regions Of The Lung
2016-10-20,Windtree Therapeutics To Host Conference Call And Webcast On Tuesday, October 25, 2016 To Provide A Business Update
2016-09-19,Windtree Therapeutics Announces FDA Fast Track Designation For AEROSURF®
2016-08-08,Windtree Receives $2.6 Million SBIR Grant To Support AEROSURF® Phase 2b Clinical Trial
2016-07-14,Windtree Awarded $1.0 Million SBIR Grant In Continuing Support Of The Development Of Aerosolized KL4 Surfactant To Address Radiation-Induced Lung Injury
2016-06-07,Windtree Therapeutics To Host Key Opinion Leader Meeting On Respiratory Distress Syndrome
2016-05-03,Windtree Therapeutics To Report First Quarter 2016 Financial Results And Host Conference Call On Thursday, May 12, 2016
2016-04-28,Windtree Therapeutics To Present At 2016 Pediatric Academic Societies Meeting
,
,
,
,
,
2017-02-16,Windtree Therapeutics' Aerosolized KL4 Surfactant Reduces Lung Inflammation And Improves Survival In A High-Pathogen Avian Influenza Preclinical Study
2017-02-15,Windtree Therapeutics Completes $10.5 Million Private Offering
2017-02-15,Windtree Therapeutics To Host A Conference Call And Webcast At 8:00 AM On Thursday, February 16, 2017 To Provide Clinical And Financial Updates
2016-12-01,Windtree Therapeutics Announces Upcoming Presentations At Hot Topics In Neonatology
2016-11-28,Windtree Therapeutics' AEROSURF® (lucinactant For Inhalation) Phase 2a Data Presented At The 2016 International Congress Of Union Of European Neonatal And Perinatal Societies
2016-11-08,Windtree Therapeutics To Present At Stifel 2016 Healthcare Conference
2016-11-03,Windtree Therapeutics Preclinical Study Results Show Potential For KL4 Surfactant As Possible Medical Countermeasure To Radiation Exposure
2016-10-24,Windtree Releases Data From Lung Deposition Study In Non-Human Primates Demonstrating Uniform Distribution Of Aerosolized KL4 Surfactant In All Regions Of The Lung
2016-10-20,Windtree Therapeutics To Host Conference Call And Webcast On Tuesday, October 25, 2016 To Provide A Business Update
2016-09-19,Windtree Therapeutics Announces FDA Fast Track Designation For AEROSURF®
2016-08-08,Windtree Receives $2.6 Million SBIR Grant To Support AEROSURF® Phase 2b Clinical Trial
2016-07-14,Windtree Awarded $1.0 Million SBIR Grant In Continuing Support Of The Development Of Aerosolized KL4 Surfactant To Address Radiation-Induced Lung Injury
2016-06-07,Windtree Therapeutics To Host Key Opinion Leader Meeting On Respiratory Distress Syndrome
2016-05-03,Windtree Therapeutics To Report First Quarter 2016 Financial Results And Host Conference Call On Thursday, May 12, 2016
2016-04-28,Windtree Therapeutics To Present At 2016 Pediatric Academic Societies Meeting
,
,
,
,
,
